Comparison of the tolerability of terbium-161 and lutetium-177 in combination with somatostatin analogues in the preclinical setting
Preprint in bioRxiv (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside
Article in Theranostics (February 2024)
Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb
Article in Nuklearmedizin - NuclearMedicine (November 2023)